PROHANCE
PROHANCE
Discontinued
DIN Number
02016087
Drug Class
Human
Market Date
Dec 31, 1993
Company
HC
squibb diagnostics, division of bristol-myers squibb canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02016087
AIG Number0124199001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08CA04 GADOTERIDOL
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification36:89.00*
Health Canada Classification
ACTIVE INGREDIENTS (1)
GADOTERIDOLActive
Strength: 279.3 MG / ML
Monograph: GADOTERIDOL